Results and prognostic factors following optimal treatment of advanced Hodgkin's disease

Recent Results Cancer Res. 1989:117:191-6. doi: 10.1007/978-3-642-83781-4_20.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Combined Modality Therapy
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / radiotherapy
  • Humans
  • Lomustine / administration & dosage
  • Mechlorethamine / administration & dosage
  • Melphalan / administration & dosage
  • Middle Aged
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Randomized Controlled Trials as Topic
  • Vinblastine / administration & dosage
  • Vincristine / administration & dosage
  • Vindesine / administration & dosage

Substances

  • Bleomycin
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Vinblastine
  • Lomustine
  • Dacarbazine
  • Doxorubicin
  • Melphalan
  • Vindesine
  • Prednisone

Supplementary concepts

  • ABVD protocol
  • CAD protocol 1
  • MOPP protocol
  • MOPP-ABV protocol